Inovio Pharmaceuticals (INO) Receivables - Net (2010 - 2026)
Inovio Pharmaceuticals (INO) posted Receivables - Net of $34000.0 for Q1 2026, down 10.53% sequentially from $38000.0 in Q4 2025, and down 97.41% YoY from $1.3 million in Q1 2025.
Inovio Pharmaceuticals (INO) Receivables - Net (2010 - 2026) Analysis & Trends
Inovio Pharmaceuticals has reported Receivables - Net for 17 years, with the latest figure at $34000.0 in Q1 2026.
- Quarterly Receivables - Net fell 97.41% year-over-year to $34000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34000.0 (down 97.41% YoY) and the FY2025 annual result came in at $38000.0, down 96.83% from the prior year.
- Receivables - Net fell to $34000.0 in Q1 2026 per INO's latest filing, from $38000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $5.1 million in Q2 2023 and troughed at $34000.0 in Q1 2026.
- A 5-year average of $1.9 million and a median of $1.7 million in 2022 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net plunged 98.17% in 2023, then jumped 3380.14% in 2024.
- Over 5 years, Receivables - Net stood at $1.7 million in 2022, then soared by 41.48% to $2.4 million in 2023, then tumbled by 50.15% to $1.2 million in 2024, then plunged by 96.83% to $38000.0 in 2025, then slipped by 10.53% to $34000.0 in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $34000.0, $38000.0, and $978590.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Inovio Pharmaceuticals | 96.32 Mn | 96.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41,000.00 |
| Jun 30, 2026 | 41,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Sep 30, 2025 | 978,590.00 |
| Sep 30, 2025 | 978,590.00 |
| Jun 30, 2025 | 840,312.00 |
| Jun 30, 2025 | 840,312.00 |
| Mar 31, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 2.55 Mn |
| Mar 31, 2024 | 2.55 Mn |